Home > Boards > US Listed > Biotechs > Akari Therapeutics (AKTX)

6K out!!! AKTX let's get this ship heading

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
makingbiigdough Member Profile
 
Followed By 121
Posts 4,708
Boards Moderated 1
Alias Born 10/20/01
160x600 placeholder
Akari Therapeutics Announces Positive Interim Data from Phase III Paroxysmal Nocturnal Hemoglobinuria (PNH) Study GlobeNewswire Inc. - 1/10/2020 9:30:09 AM
Akari Therapeutics Announces Initiation of Pivotal Phase III Trial of Nomacopan in Pediatric Hematopoietic Stem Cell Transpla... GlobeNewswire Inc. - 12/23/2019 8:45:10 AM
Akari Therapeutics Announces Pivotal Phase III Trial Design of Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Rela... GlobeNewswire Inc. - 12/2/2019 8:30:10 AM
Akari Therapeutics Reports Third Quarter 2019 Financial Results And Highlights Recent Clinical Progress GlobeNewswire Inc. - 11/4/2019 8:33:48 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/28/2019 6:01:19 AM
Securities Registration (foreign Private Issuer) (f-1) Edgar (US Regulatory) - 10/15/2019 5:24:28 PM
Securities Registration (ads, Immediate) (f-6ef) Edgar (US Regulatory) - 10/15/2019 5:09:46 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/15/2019 7:08:47 AM
Akari Therapeutics Announces New Data from Atopic Keratoconjunctivitis (AKC) Patients Supporting the Potentially Beneficial R... GlobeNewswire Inc. - 10/14/2019 8:37:28 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/10/2019 9:03:34 AM
Akari Therapeutics Announces Positive Phase II Clinical Data in Orphan Blistering Skin Disease Bullous Pemphigoid at the 28th... GlobeNewswire Inc. - 10/10/2019 8:45:02 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/4/2019 4:48:17 PM
Akari Therapeutics to Participate in Ladenburg Thalmann Healthcare Conference GlobeNewswire Inc. - 9/18/2019 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/13/2019 8:17:32 AM
Akari Therapeutics’ Nomacopan Granted U.S. Orphan Drug Designation for Bullous Pemphigoid GlobeNewswire Inc. - 9/13/2019 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/10/2019 8:22:04 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/9/2019 6:01:20 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 9/6/2019 5:08:04 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/6/2019 6:01:28 AM
Akari Therapeutics to Participate in Citi and H.C. Wainwright Conferences in Early September GlobeNewswire Inc. - 9/3/2019 7:00:00 AM
Securities Registration (foreign Private Issuer) (f-1/a) Edgar (US Regulatory) - 8/30/2019 4:04:38 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 8/30/2019 4:02:20 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/30/2019 8:13:13 AM
Akari Therapeutics’ Nomacopan Granted U.S. Orphan Drug Designation for Hematopoietic Stem Cell Transplantation-Associated T... GlobeNewswire Inc. - 8/30/2019 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/29/2019 8:29:12 AM
makingbiigdough   Thursday, 08/16/18 04:59:57 PM
Re: None
Post # of 481 
6K out!!! AKTX let's get this ship heading back in the right direction!!!!

Financials! AKTX believes it's Current Capital sufficient enough for operations going into the end of 2q of 2019!!! Great News!!! MBD

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist